oncgnostics GmbH Company
Oncgnostics develops IVD tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics.
Investors Number:
5
Total Funding:
386000000
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Industry:
At-home Testing
Founded Date:
2012-02-01
Headquarters:
Jena, Thuringen, Germany
Last Funding Date:
2015-01-29
Last Funding Type:
Series A
Funding Status:
Early Stage Venture